EGFR-targeted and MMP-activated membranolytic peptides kill cancer cells specifically in vitro and reduce tumour growth in vivo

Pramanik, Arindam, Booth, Andrew, Kobza, Dagmara et al. (4 more authors) (2026) EGFR-targeted and MMP-activated membranolytic peptides kill cancer cells specifically in vitro and reduce tumour growth in vivo. MOLECULAR PHARMACEUTICS. ISSN: 1543-8384

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2026 The Authors.
Dates:
  • Accepted: 27 March 2026
  • Published (online): 1 April 2026
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Biology (York)
The University of York > Faculty of Sciences (York) > Biology (York) > Jack Birch Unit for Molecular Carcinogenesis (York)
Funding Information:
Funder
Grant number
EPSRC
EP/R03608X/1
Date Deposited: 02 Apr 2026 16:10
Last Modified: 14 May 2026 23:16
Published Version: https://doi.org/10.1021/acs.molpharmaceut.5c01774
Status: Published online
Refereed: Yes
Identification Number: 10.1021/acs.molpharmaceut.5c01774
Open Archives Initiative ID (OAI ID):

Download

Published Version

Filename: egfr-targeted-and-mmp-activated-membranolytic-peptides-kill-cancer-cells-specifically-in-vitro-and-reduce-tumor-growth.pdf

Description: EGFR-Targeted and MMP-Activated Membranolytic Peptides Kill Cancer Cells Specifically In Vitro and Reduce Tumor Growth In Vivo

Licence: CC-BY 2.5

CLICK TO DOWNLOAD [thumbnail of EGFR-Targeted and MMP-Activated Membranolytic Peptides Kill Cancer Cells Specifically In Vitro and Reduce Tumor Growth In Vivo]

Export

Statistics

View Altmetric information about this item.


CORE (COnnecting REpositories)